GenMark Diagnostics Patents – Key Insights and Stats

GenMark Diagnostics has a total of 324 patents globally, out of which 158 have been granted. Of these 324 patents, more than 12% patents are active. The USA is where GenMark Diagnostics has filed the maximum number of patents, followed by Australia and Europe, it has generated an annual revenue of $171 million in the year 2021. Parallelly, the USA seems to be the main focused R&D centre of GenMark Diagnostics.

GenMark Diagnostics was founded in the year 2010 by Dr. John Faiz Kayyem, also known as Jon, Ph. D. Company is a molecular diagnostics company focused on developing and commercializing its sensor detection technology.

Do read about some of the most popular patents of GenMark Diagnostics which have been covered by us in this article and also you can find GenMark Diagnostics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over GenMark Diagnostics patent portfolio.

How many patents does the founder and the CEO of GenMark Diagnostics have?

The founder, Dr. John Faiz Kayyem, has 38 patents. The CEO, Tanya Monga, has 5 patents.

How many patents does GenMark Diagnostics have?

GenMark Diagnostics has a total of 324 patents globally. These patents belong to 75 unique patent families. Out of 324 patents, 42 patents are active.

How Many Patents did GenMark Diagnostics File Every Year?

GenMark Diagnostics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantGenMark Diagnostics Applications FiledGenMark Diagnostics Patents Granted
201116
201222
2013165
2014133
2015131
20161
201755
20181210
201968
202034
202133
20221

How many GenMark Diagnostics patents are Alive/Dead?

GenMark Diagnostics Patent Portfolio

How Many Patents did GenMark Diagnostics File in Different Countries?

GenMark Diagnostics Worldwide Patent Filing

Countries in which GenMark Diagnostics Filed Patents

CountryPatents
United States Of America96
Australia44
Europe43
Japan30
Germany24
United Kingdom12
Austria11
Hong Kong (S.A.R.)8
Spain4
Canada4
Denmark2
China2
United Arab Emirates1
Portugal1
Singapore1
Saudi Arabia1

Where are Research Centres of GenMark Diagnostics Patents Located?

R&D Centres of GenMark Diagnostics

10 Best GenMark Diagnostics Patents

US20040053290A1 is the most popular patent in the GenMark Diagnostics portfolio. It has received 577 citations so far from companies like Motorola, Cabot Corporation, and 3M Innovative.

Below is the list of 10 most cited patents of GenMark Diagnostics:

Publication NumberCitation Count
US20040053290A1577
US20040146909A1479
US6740518B1404
US6361958B1347
US6942771B1340
US7160678B1330
US20030175947A1319
US6875619B2276
US7172897B2238
US6518024B2212

EXCLUSIVE INSIGHTS COMING SOON!

What are GenMark Diagnostics’ key innovation segments?

What Technologies are Covered by GenMark Diagnostics?

This image has an empty alt attribute; its file name is Tech-Area-Blur-22-1024x576.webp

The chart below distributes patents filed by GenMark Diagnostics in different countries on the basis of the technology protected in patents. It also represents the markets where GenMark Diagnostics thinks it’s important to protect particular technology inventions.

This image has an empty alt attribute; its file name is Tech-Protected-blur-22-1024x576.jpg

R&D Focus: How GenMark Diagnostics’ search focus changed over the years?

This image has an empty alt attribute; its file name is Technology-Through-the-year-Blur-22-1024x576.jpg

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by GenMark Diagnostics?

Table of Content

Insights you may find interesting

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.